These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24243636)

  • 41. Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly.
    Clemmons DR; Bidlingmaier M
    Front Endocrinol (Lausanne); 2023; 14():1266339. PubMed ID: 38027199
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A nationwide survey of mortality in acromegaly.
    Kauppinen-Mäkelin R; Sane T; Reunanen A; Välimäki MJ; Niskanen L; Markkanen H; Löyttyniemi E; Ebeling T; Jaatinen P; Laine H; Nuutila P; Salmela P; Salmi J; Stenman UH; Viikari J; Voutilainen E
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4081-6. PubMed ID: 15886256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term treatment outcome in acromegaly.
    Holdaway IM; Rajasoorya CR; Gamble GD; Stewart AW
    Growth Horm IGF Res; 2003 Aug; 13(4):185-92. PubMed ID: 12914751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does acromegaly enhance mortality?
    Ayuk J; Sheppard MC
    Rev Endocr Metab Disord; 2008 Mar; 9(1):33-9. PubMed ID: 18075787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Growth hormone measurements in the diagnosis and monitoring of acromegaly.
    Sata A; Ho KK
    Pituitary; 2007; 10(2):165-72. PubMed ID: 17458702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of morbidity and mortality in acromegaly: an Italian survey.
    Arosio M; Reimondo G; Malchiodi E; Berchialla P; Borraccino A; De Marinis L; Pivonello R; Grottoli S; Losa M; Cannavò S; Minuto F; Montini M; Bondanelli M; De Menis E; Martini C; Angeletti G; Velardo A; Peri A; Faustini-Fustini M; Tita P; Pigliaru F; Borretta G; Scaroni C; Bazzoni N; Bianchi A; Appetecchia M; Cavagnini F; Lombardi G; Ghigo E; Beck-Peccoz P; Colao A; Terzolo M;
    Eur J Endocrinol; 2012 Aug; 167(2):189-98. PubMed ID: 22596288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update.
    Gadelha MR; Kasuki L; Lim DST; Fleseriu M
    Endocr Rev; 2019 Feb; 40(1):268-332. PubMed ID: 30184064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Incidence of Cancer Among Acromegaly Patients: Results From the German Acromegaly Registry.
    Petroff D; Tönjes A; Grussendorf M; Droste M; Dimopoulou C; Stalla G; Jaursch-Hancke C; Mai M; Schopohl J; Schöfl C
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3894-902. PubMed ID: 26244491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for the use of igf-I as a predictor of mortality in acromegaly is lacking.
    Ayuk J; Sheppard MC; Clayton RN; Bates AS; Stewart PM
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5867-8; author reply 5868. PubMed ID: 15531556
    [No Abstract]   [Full Text] [Related]  

  • 50. The role of cumulative growth hormone exposure in determining mortality and morbidity in acromegaly: a single centre study.
    Varadhan L; Reulen RC; Brown M; Clayton RN
    Pituitary; 2016 Jun; 19(3):251-61. PubMed ID: 26724807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased mortality in acromegaly is due to vascular and respiratory disease and is normalised by control of GH levels-A retrospective analysis from the UK Acromegaly Register 1970-2016.
    Orme S; McNally R; James PW; Davis J; Ayuk J; Higham C; Wass J;
    Clin Endocrinol (Oxf); 2024 Jun; 100(6):558-564. PubMed ID: 38652736
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulin-like growth factor-1, growth hormone and disease outcomes in acromegaly: A population study.
    Thomas M; Berni E; Jenkins-Jones S; Wensley S; Poole CD; Currie CJ; Brownrigg J; Ayuk J; Rees DA
    Clin Endocrinol (Oxf); 2021 Jul; 95(1):143-152. PubMed ID: 33749903
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Follow-up of treated acromegaly: similarities and differences in assessing the response to different primary treatment modalities.
    Sheppard MC
    Growth Horm IGF Res; 2000 Apr; 10 Suppl B():S115-8. PubMed ID: 10984266
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT® validation study.
    Giustina A; Bronstein MD; Chanson P; Petersenn S; Casanueva FF; Sert C; Houchard A; Melmed S
    Pituitary; 2019 Oct; 22(5):476-487. PubMed ID: 31338660
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly.
    Sherlock M; Reulen RC; Alonso AA; Ayuk J; Clayton RN; Sheppard MC; Hawkins MM; Bates AS; Stewart PM
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4216-23. PubMed ID: 19808848
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Letter re: Monitoring the response to treatment in acromegaly.
    Ayuk J; Sheppard MC; Bates AS; Stewart PM
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4980. PubMed ID: 16087964
    [No Abstract]   [Full Text] [Related]  

  • 57. MANAGEMENT OF ENDOCRINE DISEASE: Bone disorders associated with acromegaly: mechanisms and treatment.
    Mazziotti G; Lania AGA; Canalis E
    Eur J Endocrinol; 2019 Aug; 181(2):R45-R56. PubMed ID: 31100715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systemic complications of acromegaly: epidemiology, pathogenesis, and management.
    Colao A; Ferone D; Marzullo P; Lombardi G
    Endocr Rev; 2004 Feb; 25(1):102-52. PubMed ID: 14769829
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oncological complications of excess GH in acromegaly.
    Webb SM; Casanueva F; Wass JA
    Pituitary; 2002 Jan; 5(1):21-5. PubMed ID: 12638722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group.
    Orme SM; McNally RJ; Cartwright RA; Belchetz PE
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2730-4. PubMed ID: 9709939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.